SCYNEXIS, Inc. to Present at 10th Annual JMP Securities Life Sciences Conference

RESEARCH TRIANGLE PARK, N.C., June 18, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that David Angulo, M.D., SCYNEXIS' Chief Medical Officer, will present at the 10th Annual JMP Securities Life Sciences Conference at The St. Regis New York in New York City on Wednesday, June 24, 2015, at 11:00 a.m. ET.

A live webcast will be available on the investors section of the Company's website: A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

About SCYNEXIS, Inc.

SCYNEXIS is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. We are developing our lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. For more information, visit

CONTACT: Media Relations Heather Savelle MacDougall Biomedical Communications Tel: 781-235-3060 Investor Relations Jillian Connell The Trout Group LLC Tel: 646.378.2956

Source:SCYNEXIS, Inc.